Intuitive Surgical Company Profile (NASDAQ:ISRG)

About Intuitive Surgical

Intuitive Surgical logoIntuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation solution and three-dimensional (3-D), high-definition vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies. It focuses on five surgical specialties: gynecologic surgery, urologic surgery, general surgery, cardiothoracic surgery, and head and neck surgery.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ISRG
  • CUSIP: 46120E60
Key Metrics:
  • Previous Close: $736.86
  • 50 Day Moving Average: $691.73
  • 200 Day Moving Average: $677.32
  • 52-Week Range: $557.00 - $738.80
  • Trailing P/E Ratio: 39.34
  • Foreward P/E Ratio: 27.77
  • P/E Growth: 2.65
  • Market Cap: $28.58B
  • Outstanding Shares: 38,786,000
  • Beta: 0.55
  • Net Margins: 27.21%
  • Return on Equity: 14.24%
  • Return on Assets: 12.74%
  • Current Ratio: 5.45%
  • Quick Ratio: 5.14%
Additional Links:
Companies Related to Intuitive Surgical:

Analyst Ratings

Consensus Ratings for Intuitive Surgical (NASDAQ:ISRG) (?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.53)
Consensus Price Target: $735.93 (0.13% downside)

Analysts' Ratings History for Intuitive Surgical (NASDAQ:ISRG)
DateFirmActionRatingPrice TargetDetails
2/14/2017Bank of America CorpSet Price TargetBuy$770.00 -> $800.00View Rating Details
1/25/2017Canaccord GenuityReiterated RatingBuyView Rating Details
1/14/2017WedbushReiterated RatingOutperform$800.00View Rating Details
1/4/2017Evercore ISIDowngradeBuy -> Hold$690.00View Rating Details
10/21/2016Barclays PLCReiterated RatingOverweight$750.00 -> $760.00View Rating Details
10/19/2016RBC Capital MarketsSet Price TargetHold$750.00 -> $760.00View Rating Details
10/19/2016Royal Bank of CanadaBoost Price TargetSector Perform$750.00 -> $760.00View Rating Details
10/13/2016Wells Fargo & CoInitiated CoverageOutperformView Rating Details
9/20/2016J P Morgan Chase & CoReiterated RatingBuyView Rating Details
9/20/2016BTIG ResearchReiterated RatingHoldView Rating Details
9/19/2016Leerink SwannReiterated RatingOutperform$780.00View Rating Details
8/26/2016Raymond James Financial, Inc.Initiated CoverageOutperformView Rating Details
7/21/2016Northland SecuritiesDowngradeMarket Perform -> Under Perform$600.00View Rating Details
7/20/2016Citigroup Inc.Boost Price TargetBuy$723.00 -> $779.00View Rating Details
7/20/2016Piper Jaffray CompaniesReiterated RatingNeutral$610.00 -> $700.00View Rating Details
7/20/2016Stifel NicolausBoost Price TargetBuy$700.00 -> $800.00View Rating Details
6/2/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$633.00 -> $674.00View Rating Details
4/20/2016Morgan StanleyReiterated RatingBuyView Rating Details
4/14/2016Sterne Agee CRTReiterated RatingNeutralView Rating Details
1/22/2016William BlairReiterated RatingBuyView Rating Details
7/22/2015Jefferies Group LLCBoost Price TargetBuy$616.00 -> $675.00View Rating Details
(Data available from 2/25/2015 forward)


Earnings History for Intuitive Surgical (NASDAQ:ISRG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/24/2017Q416$5.99$6.09$739.65 million$757.00 millionViewN/AView Earnings Details
10/18/2016Q3$5.13$6.19$650.49 million$682.90 millionViewListenView Earnings Details
7/19/2016Q216$4.97$5.62$640.69 million$670.00 millionViewListenView Earnings Details
4/19/2016Q1$4.33$4.42$593.08 million$594.50 millionViewListenView Earnings Details
1/21/2016Q4$5.04$5.89$655.32 million$676.50 millionViewListenView Earnings Details
10/20/2015Q3$4.23$5.24$580.37 million$590.00 millionViewListenView Earnings Details
7/21/2015Q2$3.98$4.57$566.86 million$586.10 millionViewListenView Earnings Details
4/21/2015Q1$3.87$3.57$535.10 million$532.10 millionViewListenView Earnings Details
1/22/2015Q4$4.38$4.92$601.00 millionViewListenView Earnings Details
10/21/2014Q314$3.72$3.92$515.44 million$550.00 millionViewListenView Earnings Details
7/22/2014Q214$2.82$3.73$502.23 million$512.00 millionViewListenView Earnings Details
4/22/2014Q114$3.31$1.13$507.04 million$464.70 millionViewListenView Earnings Details
1/23/2014Q413$3.81$4.28$576.00 million$576.20 millionViewListenView Earnings Details
10/17/2013Q313$3.40$3.99$525.47 million$499.00 millionViewListenView Earnings Details
7/18/2013Q2 2013$4.04$3.90$594.58 million$578.50 millionViewListenView Earnings Details
4/18/2013Q1 2013$4.02$4.56$583.59 million$611.40 millionViewListenView Earnings Details
1/22/2013Q4 2012$4.02$4.25$584.36 million$609.30 millionViewListenView Earnings Details
10/16/2012$3.51$4.46ViewN/AView Earnings Details
7/19/2012$3.57$3.75ViewN/AView Earnings Details
4/17/2012$3.15$3.50ViewN/AView Earnings Details
1/19/2012$3.35$3.75ViewN/AView Earnings Details
10/18/2011$2.81$3.05ViewN/AView Earnings Details
7/19/2011$2.71$2.91ViewN/AView Earnings Details
4/19/2011$2.49$2.59ViewN/AView Earnings Details
1/20/2011$2.25$3.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Intuitive Surgical (NASDAQ:ISRG)
Current Year EPS Consensus Estimate: $23.49 EPS
Next Year EPS Consensus Estimate: $26.53 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20162$5.35$5.88$5.62
Q1 20171$3.96$3.96$3.96
Q2 20171$4.55$4.55$4.55
Q3 20171$4.89$4.89$4.89
Q4 20171$5.69$5.69$5.69
(Data provided by Zacks Investment Research)


Dividend History for Intuitive Surgical (NASDAQ:ISRG)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Intuitive Surgical (NASDAQ:ISRG)
Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 91.16%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/24/2017Curet MyriamSVPSell222$729.80$162,015.60View SEC Filing  
2/21/2017Mark J MeltzerSVPSell8,750$724.82$6,342,175.00View SEC Filing  
2/7/2017Colin MoralesSVPSell1,000$703.99$703,990.00View SEC Filing  
2/2/2017Marshall MohrCFOSell2,000$700.00$1,400,000.00View SEC Filing  
1/27/2017Lonnie M SmithDirectorSell1,000$684.38$684,380.00View SEC Filing  
12/13/2016David J RosaEVPSell7,200$650.00$4,680,000.00View SEC Filing  
12/13/2016Lonnie M SmithDirectorSell1,000$650.00$650,000.00View SEC Filing  
11/17/2016Lonnie M SmithDirectorSell275$646.50$177,787.50View SEC Filing  
11/7/2016Gary S GuthartCEOSell13,515$680.68$9,199,390.20View SEC Filing  
8/22/2016Mark J MeltzerSVPSell3,000$688.33$2,064,990.00View SEC Filing  
8/4/2016Alan J LevyDirectorSell3,188$694.11$2,212,822.68View SEC Filing  
8/1/2016Gary S GuthartCEOSell13,400$698.00$9,353,200.00View SEC Filing  
7/27/2016Curet MyriamSVPSell4,250$684.39$2,908,657.50View SEC Filing  
7/27/2016Marshall MohrCFOSell5,000$684.09$3,420,450.00View SEC Filing  
6/2/2016Salvatore BrognaEVPSell600$630.96$378,576.00View SEC Filing  
6/1/2016Salvatore BrognaEVPSell20,406$632.66$12,910,059.96View SEC Filing  
5/17/2016Curet MyriamSVPSell530$629.36$333,560.80View SEC Filing  
5/17/2016Lonnie M SmithDirectorSell2,000$627.23$1,254,460.00View SEC Filing  
5/3/2016George Stalk JrDirectorSell7,644$618.70$4,729,342.80View SEC Filing  
5/2/2016Marshall MohrCFOSell5,000$631.63$3,158,150.00View SEC Filing  
4/27/2016Mark J MeltzerSVPSell16,625$631.52$10,499,020.00View SEC Filing  
4/26/2016Alan J LevyDirectorSell542$631.72$342,392.24View SEC Filing  
4/25/2016Amal M JohnsonDirectorSell2,500$640.00$1,600,000.00View SEC Filing  
4/22/2016Curet MyriamSVPSell8,173$637.75$5,212,330.75View SEC Filing  
4/22/2016Eric H HalvorsonDirectorSell5,688$639.21$3,635,826.48View SEC Filing  
3/14/2016Eric H HalvorsonDirectorSell4,438$593.16$2,632,444.08View SEC Filing  
3/14/2016Mark J MeltzerSVPSell12,500$589.00$7,362,500.00View SEC Filing  
3/11/2016Curet MyriamSVPSell2,000$582.50$1,165,000.00View SEC Filing  
3/11/2016Jamie SamathVPSell8,026$575.95$4,622,574.70View SEC Filing  
3/10/2016Alan J LevyDirectorSell5,000$569.14$2,845,700.00View SEC Filing  
3/7/2016Colin MoralesSVPSell2,500$575.00$1,437,500.00View SEC Filing  
3/4/2016Colin MoralesSVPSell884$571.49$505,197.16View SEC Filing  
3/3/2016Marshall MohrCFOSell2,500$575.00$1,437,500.00View SEC Filing  
3/2/2016Salvatore BrognaEVPSell1,882$567.37$1,067,790.34View SEC Filing  
2/19/2016Colin MoralesSVPSell5,530$542.83$3,001,849.90View SEC Filing  
2/4/2016Curet MyriamSVPSell2,000$551.00$1,102,000.00View SEC Filing  
2/4/2016Marshall MohrCFOSell2,500$550.00$1,375,000.00View SEC Filing  
1/29/2016Mark J. MeltzerSVPSell4,125$527.59$2,176,308.75View SEC Filing  
12/14/2015Salvatore BrognaEVPSell2,734$530.00$1,449,020.00View SEC Filing  
11/20/2015Mark J. MeltzerSVPSell1,625$515.00$836,875.00View SEC Filing  
10/26/2015Mark J. MeltzerSVPSell2,500$498.37$1,245,925.00View SEC Filing  
10/23/2015Lonnie M. SmithDirectorSell10,328$500.00$5,164,000.00View SEC Filing  
9/1/2015Salvatore BrognaEVPSell374$501.99$187,744.26View SEC Filing  
8/18/2015George Stalk JrDirectorSell4,726$532.03$2,514,373.78View SEC Filing  
7/27/2015Gary S GuthartCEOSell17,255$541.98$9,351,864.90View SEC Filing  
7/27/2015Mark J MeltzerSVPSell4,750$542.03$2,574,642.50View SEC Filing  
7/24/2015David J RosaEVPSell2,800$550.20$1,540,560.00View SEC Filing  
7/24/2015Jamie SamathVPSell5,000$550.00$2,750,000.00View SEC Filing  
7/24/2015Lonnie M SmithDirectorSell20,000$544.62$10,892,400.00View SEC Filing  
6/9/2015Alan J LevyDirectorSell417$495.41$206,585.97View SEC Filing  
6/8/2015Gary S GuthartCEOSell17,840$492.16$8,780,134.40View SEC Filing  
5/29/2015Lonnie M SmithDirectorSell2,000$488.68$977,360.00View SEC Filing  
5/27/2015Curet MyriamSVPSell1,000$489.35$489,350.00View SEC Filing  
5/18/2015Colin MoralesSVPSell13,824$503.29$6,957,480.96View SEC Filing  
4/28/2015Curet MyriamSVPSell261$504.54$131,684.94View SEC Filing  
4/27/2015Jerome J McnamaraEVPSell15,000$504.06$7,560,900.00View SEC Filing  
4/27/2015Marshall MohrCFOSell10,000$504.08$5,040,800.00View SEC Filing  
4/24/2015Lonnie M SmithDirectorSell20,000$508.03$10,160,600.00View SEC Filing  
3/2/2015Salvatore BrognaSVPSell1,375$500.98$688,847.50View SEC Filing  
2/6/2015Mark J RubashDirectorSell5,000$520.00$2,600,000.00View SEC Filing  
1/27/2015Jerome J McnamaraEVPSell15,000$511.32$7,669,800.00View SEC Filing  
1/27/2015Lonnie M SmithDirectorSell20,000$511.31$10,226,200.00View SEC Filing  
1/27/2015Marshall MohrCFOSell5,000$511.14$2,555,700.00View SEC Filing  
12/8/2014Lonnie M SmithDirectorSell1,700$511.24$869,108.00View SEC Filing  
12/1/2014Salvatore BrognaSVPSell1,375$515.87$709,321.25View SEC Filing  
11/24/2014Colin MoralesSVPSell9,565$520.82$4,981,643.30View SEC Filing  
10/31/2014Marshall MohrCFOSell7,500$500.00$3,750,000.00View SEC Filing  
10/30/2014Floyd D Md LoopDirectorSell2,125$488.95$1,039,018.75View SEC Filing  
10/27/2014Floyd D Md LoopDirectorSell15,209$475.71$7,235,073.39View SEC Filing  
10/27/2014Jerome J McnamaraEVPSell15,000$473.76$7,106,400.00View SEC Filing  
10/27/2014Marshall MohrCFOSell2,500$473.50$1,183,750.00View SEC Filing  
9/2/2014Salvatore BrognaSVPSell12,626$472.06$5,960,229.56View SEC Filing  
8/26/2014Colin MoralesSVPSell4,105$478.66$1,964,899.30View SEC Filing  
7/28/2014Jerome J McnamaraEVPSell9,167$465.59$4,268,063.53View SEC Filing  
7/25/2014Colin MoralesSVPSell2,000$461.99$923,980.00View SEC Filing  
2/27/2014Colin MoralesSVPSell1,000$445.00$445,000.00View SEC Filing  
12/3/2012Lonnie M SmithChairmanSell1,000$525.98$525,980.00View SEC Filing  
9/4/2012Salvatore BrognaSVPSell1,250$490.25$612,812.50View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Intuitive Surgical (NASDAQ:ISRG)
DateHeadline logo3 Healthcare Stocks to Invest In (NASDAQ:ISRG) - February 25 at 5:44 PM
News IconGlobal surgical robots market forecast 2022 made available by top research firm (NASDAQ:ISRG) - February 25 at 12:17 AM logoInsider Trading Activity Intuitive Surgical, Inc. (NASDAQ:ISRG) – SVP Sold 222 shares of Stock (NASDAQ:ISRG) - February 25 at 12:17 AM
News IconWhat Does The Chart For Intuitive Surgical, Inc. (ISRG) Tell Us Presently? - NY Stock News (NASDAQ:ISRG) - February 24 at 7:15 PM
News IconMarket Update: Following the Charts for Intuitive Surgical, Inc. (NASDAQ:ISRG) - Baxter Review (NASDAQ:ISRG) - February 24 at 7:15 PM
News IconAnalysts Peeling Back The Layers on Intuitive Surgical, Inc. (NASDAQ:ISRG): Consensus Take - Winfield Review (NASDAQ:ISRG) - February 24 at 7:15 PM logoInsider Trading Activity Intuitive Surgical, Inc. (NASDAQ:ISRG) – SVP Sold 222 shares of Stock - Market Exclusive (NASDAQ:ISRG) - February 24 at 7:15 PM logoForm 4 INTUITIVE SURGICAL INC For: Feb 17 Filed by: Myriam Curet (NASDAQ:ISRG) - February 22 at 11:15 PM logoForm 4 INTUITIVE SURGICAL INC For: Feb 17 Filed by: GUTHART GARY S (NASDAQ:ISRG) - February 22 at 6:12 PM
News IconMedical robots market worth 12.80 billion USD by 2021 according to new research report (NASDAQ:ISRG) - February 22 at 12:35 PM logoBaron Opportunity Fund Comments on Intuitive Surgical (NASDAQ:ISRG) - February 22 at 12:35 PM logoForm 4 INTUITIVE SURGICAL INC For: Feb 15 Filed by: Rosa David J. (NASDAQ:ISRG) - February 18 at 11:03 AM
News IconEPS Forecast Of Intuitive Surgical, Inc. (NASDAQ:ISRG) Set At $4.95 - Transcript Daily (NASDAQ:ISRG) - February 16 at 8:07 AM
News IconIntuitive Surgical, Inc. (ISRG) Stock Price Target Moved to $800.00 at Bank of America Corporation - The Ledger Gazette (NASDAQ:ISRG) - February 15 at 9:09 PM
News IconPeeling Back The Layers on Intuitive Surgical, Inc. (NASDAQ:ISRG): Analysts & Street Weigh In - Winfield Review (NASDAQ:ISRG) - February 15 at 6:05 AM logoNoteworthy Tuesday Option Activity: ISRG, MMM, MGM (NASDAQ:ISRG) - February 14 at 7:22 PM
News IconTop Analyst Upgrades and Downgrades: Intuitive Surgical, Restaurant Brands, Scorpio Tankers, Teva, Under Armour, Zillow and Many More (NASDAQ:ISRG) - February 14 at 10:46 AM
News IconResearch report explores the lung cancer surgery market worth 29.99 billion USD by 2021 (NASDAQ:ISRG) - February 13 at 7:03 PM logoBaron Funds' Fifth Avenue Growth Fund Comments on Intuitive Surgical (NASDAQ:ISRG) - February 13 at 7:03 PM logoIntuitive Surgical Reports New Employee Option Grants for February 2017 (NASDAQ:ISRG) - February 13 at 7:03 PM logoBetter Buy: Intuitive Surgical, Inc. vs. Accuray Incorporated (NASDAQ:ISRG) - February 13 at 9:31 AM
News IconShares in Focus: Intuitive Surgical, Inc. (NASDAQ:ISRG) - Midway Monitor (NASDAQ:ISRG) - February 10 at 11:48 PM
News IconWashington Supreme Court deals a blow to Intuitive Surgical (NASDAQ:ISRG) - February 10 at 6:46 PM logoShort Interest Increases 191% For ISRG (NASDAQ:ISRG) - February 10 at 6:46 PM
News IconPrice Target Of Intuitive Surgical, Inc. (NASDAQ:ISRG)At $748.636 ... - Transcript Daily (NASDAQ:ISRG) - February 10 at 4:56 AM
News IconShares of Intuitive Surgical, Inc. (ISRG) Sees Large Outflow of Money - Highland Mirror (NASDAQ:ISRG) - February 10 at 4:56 AM
News IconIntuitive Surgical's Quarter in 6 Metrics - Fox Business (NASDAQ:ISRG) - February 10 at 4:56 AM
News IconIntuitive Surgical warns of risks on Obamacare repeal, NAFTA withdrawal, Brexit (NASDAQ:ISRG) - February 9 at 6:56 PM logoINTUITIVE SURGICAL INC Financials (NASDAQ:ISRG) - February 9 at 6:56 PM logoIntuitive Surgical's Quarter in 6 Metrics (NASDAQ:ISRG) - February 9 at 9:31 AM logoINTUITIVE SURGICAL INC Files SEC form 10-K, Annual Report (NASDAQ:ISRG) - February 8 at 6:45 PM logoINTUITIVE SURGICAL INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:ISRG) - February 8 at 6:45 PM
News IconInvestor Monitor: Narrowing in on Intuitive Surgical, Inc. (NASDAQ:ISRG) - Providence Standard (NASDAQ:ISRG) - February 8 at 12:19 AM logoWhy Intuitive Surgical Is Increasing R&D Spending by Over 30% (NASDAQ:ISRG) - February 7 at 10:58 AM
News IconTop Gainers of the Day: Intuitive Surgical, Inc. (NASDAQ:ISRG) from Medical Appliances & Equipment (NASDAQ:ISRG) - February 6 at 11:05 PM logo10-K: INTUITIVE SURGICAL INC (NASDAQ:ISRG) - February 6 at 6:03 PM
News IconIntuitive Surgical INC (ISRG) Holder Turner Investments LP Trimmed Its Holding by $5.80 Million (NASDAQ:ISRG) - February 6 at 6:03 PM
News IconIntuitive Surgical, Inc. (NASDAQ:ISRG) Mean Price Target At ... - Transcript Daily (NASDAQ:ISRG) - February 6 at 10:29 AM
News IconIntuitive Surgical, Inc. (NASDAQ:ISRG) from Medical Appliances & Equipment – Todays Top Gains (NASDAQ:ISRG) - February 3 at 6:35 PM logoHere's What Allowed This "Cutting-Edge" Stock to Jump 9% in January (NASDAQ:ISRG) - February 3 at 10:58 AM
News IconIntuitive Surgical, Inc. (NASDAQ:ISRG) EPS Estimate At $4.95 - Transcript Daily (NASDAQ:ISRG) - February 2 at 6:42 PM logoETFs with exposure to Intuitive Surgical, Inc. : February 2, 2017 (NASDAQ:ISRG) - February 2 at 6:42 PM
News IconIntuitive Surgical, Inc. (NASDAQ:ISRG) Target Price At $748.636 - Transcript Daily (NASDAQ:ISRG) - February 1 at 11:47 PM logo6 Must-See Quotes From Intuitive Surgical's Management (NASDAQ:ISRG) - February 1 at 1:37 PM logoForm 4 INTUITIVE SURGICAL INC For: Jan 27 Filed by: SMITH LONNIE M (NASDAQ:ISRG) - January 28 at 12:59 AM
News IconIs Intuitive Surgical, Inc. (NASDAQ:ISRG), a large market cap stock a smart buy? (NASDAQ:ISRG) - January 28 at 12:59 AM
News IconValicenti Advisory Services Inc Boosts Position by $4319923 in Intuitive Surgical (ISRG) (NASDAQ:ISRG) - January 27 at 12:45 AM
News IconThe Intuitive Surgical, Inc. (ISRG) Shares Sold by Riverhead Capital Management LLC (NASDAQ:ISRG) - January 27 at 12:45 AM logoIntuitive Surgical, Inc. :ISRG-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017 (NASDAQ:ISRG) - January 27 at 12:45 AM logoMorgan Dempsey Capital Management Llc Buys Target Corp, Cisco Systems Inc, Reynolds American ... (NASDAQ:ISRG) - January 27 at 12:45 AM


What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

Where is Intuitive Surgical's stock going? Where will Intuitive Surgical's stock price be in 2017?

19 analysts have issued 1 year price objectives for Intuitive Surgical's shares. Their forecasts range from $600.00 to $800.00. On average, they anticipate Intuitive Surgical's share price to reach $735.93 in the next twelve months.

When will Intuitive Surgical announce their earnings?

Intuitive Surgical is scheduled to release their next quarterly earnings announcement on Monday, April, 17th 2017.

What are analysts saying about Intuitive Surgical stock?

Here are some recent quotes from research analysts about Intuitive Surgical stock:

  • Canaccord Genuity analysts commented, "ISRG is shaping up to be one of the most compelling large-cap med-tech stocks in the sector, in our view; thus, we stay buyers of the stock. Coming off one of the most impressive years in its nearly two-decade run - delivering 13% revenue growth and 26% pro-forma EPS growth, and building its cash position to ~$5 Billion ' ISRG outlined in detail what we believe is the most robust new product pipeline in its history (which we discuss in detail below). Granted, the firm guided to a significant ramp in OpEx in 2017 (+15-18% Y/Y) - primary R&D spending (i.e. $80M in accelerated R&D projects in 2017) - to fund important clinical trials (cost/economic studies, molecular imaging), augment development of key projects (catheter robotics, new molecular imaging modalities, diagnostics/biopsy platform) and 'grease' the regulatory machinery around the world (China, Japan, Brazil, and US). This will undoubtedly tamp down pro forma EPS growth in 2017E (we now model 5% Y/Y vs. 13% previously); however, we think the launch of SP during 2017, coupled with OpEx leverage (as the R&D surge abates next year), will accelerate EPS growth back to the mid-teens at least in 2018E (we model 16% Y/ Y growth). With a few of the aforementioned, unique, compelling new revenue drivers poised to join the party in 2019 and beyond, we think bears will find it hard to bet against the 'Surge.' To wit, we view the current spending surge as a bullish indication, positively reinforcing how management views business trends playing out over the next several years. We reiterate a Buy rating and $800 target price (which excludes over $75 in cash/share after the $2B accelerated share repurchase slated for immediate execution)." (1/25/2017)
  • According to Zacks Investment Research, "Over the past one year Intuitive Surgical has outperformed the broader industry trends in terms of price performance. Additionally, a favorable estimate revision trend for the current year holds considerable promise for the stock. Intuitive Surgical has been gaining prominence in the niche markets, courtesy of the growing adoption of the da Vinci system (a surgical platform) among physicians and overall growth in global procedures. Furthermore, incremental spending on product development and higher investments in international markets are prudent moves that will drive long-term growth. However, Intuitive Surgical faces the risk of lower capital spending by hospitals. Thus a major source of risk is pricing pressure. Additionally, challenging foreign exchange movements are likely to mar prospects." (1/17/2017)

  • J P Morgan Chase & Co analysts commented, "Over the weekend, we attended the second annual Global Symposium on Robotic Assisted and Minimally Invasive Hernia Repair, which was a gathering of >250 general surgeons in New York. The meeting was positive for Intuitive Surgical (ISRG), as interest in robotic hernia repair has increased since last year, with a number of presentations highlighting both clinical and cost data, while there was broader acknowledgement that robotics is the future for hernia repair (including by ISRG’s Chief Medical Officer, who not surprisingly, spoke positively about potential future adoption, with potential for it to eventually reach 40-50% penetration). Following the conference, along with our recent physician survey (see note here), we are increasingly confident that hernia is a legitimate opportunity for ISRG, and should continue to be a primary driver of sustainable procedure growth over the near to intermediate term." (9/20/2016)

Who owns Intuitive Surgical stock?

Intuitive Surgical's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (5.67%), State Street Corp (4.21%), Baillie Gifford & Co. (4.03%), Brown Advisory Inc. (1.92%), Edgewood Management LLC (1.71%) and Janus Capital Management LLC (0.61%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Jerome J Mcnamara, Lonnie M Smith, Mark J Meltzer, Marshall Mohr and Salvatore Brogna.

Who sold Intuitive Surgical stock? Who is selling Intuitive Surgical stock?

Intuitive Surgical's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Orbimed Advisors LLC, Brown Advisory Inc., Two Sigma Investments LP, Sandler Capital Management, Credit Agricole S A, Baird Financial Group Inc. and Baillie Gifford & Co.. Company insiders that have sold Intuitive Surgical stock in the last year include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Marshall Mohr and Salvatore Brogna.

Who bought Intuitive Surgical stock? Who is buying Intuitive Surgical stock?

Intuitive Surgical's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, State Street Corp, Janus Capital Management LLC, Asset Management One Co. Ltd., Russell Investments Group Ltd., NN Investment Partners Holdings N.V., Guggenheim Capital LLC and Flinton Capital Management LLC.

How do I buy Intuitive Surgical stock?

Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Intuitive Surgical stock cost?

One share of Intuitive Surgical stock can currently be purchased for approximately $736.86.

Intuitive Surgical (NASDAQ:ISRG) Chart for Saturday, February, 25, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Earnings History Chart

Earnings by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Dividend History Chart

Dividend Payments by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Last Updated on 2/25/2017 by Staff